Evidence map›Paper›PMID 40337374›Full record

ReviewACS catalysis2025

Engineered Biocatalysts for the Asymmetric Synthesis of d-Phenylalanines.

Raluca Bianca Tomoiagă, Levente Csaba Nagy, Krisztina Boros, Mădălina Elena Moisă, László Csaba Bencze

Abstract readReview
In one paragraph

Review in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raluca Bianca TomoiagăEnzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Arany János Street 11, RO-400028 Cluj-Napoca, Romania.
Levente Csaba NagyEnzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Arany János Street 11, RO-400028 Cluj-Napoca, Romania.
Krisztina BorosEnzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Arany János Street 11, RO-400028 Cluj-Napoca, Romania.
Mădălina Elena MoisăEnzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Arany János Street 11, RO-400028 Cluj-Napoca, Romania.
László Csaba BenczeEnzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, Arany János Street 11, RO-400028 Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0003-0956-9749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzymatic synthesis of d-phenylalanines, important chiral building blocks for several pharmaceuticals and fine chemicals, has been widely explored. Their asymmetric synthesis of high atom economy and accessible prochiral starting materials is highly attractive, while the expanding toolbox of protein engineering facilitates access to biocatalysts tailored for these processes. Accordingly, this Review provides an overview of the protein engineering efforts of enzymes involved in the asymmetric synthetic pathways for d-phenylalanines. The engineering efforts on d-amino acid dehydrogenases, d-amino acid transaminases, and phenylalanine ammonia-lyases to produce d-phenylalanines are thoroughly examined, while their application in (chemo)enzymatic cascades is also discussed. For an improved efficiency of the cascades, the protein engineering of l-amino acid deaminases and/or l-amino acid oxidases for an increased transformation of phenylalanines is also addressed.

Identifiers

PMID40337374
PMCPMC12054356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.